Literature DB >> 3153297

Continuous arteriovenous hemofiltration in children.

K V Lieberman1.   

Abstract

Continuous arteriovenous hemofiltration (CAVH) is an extracorporeal technique for the treatment of hypervolemia and electrolyte disturbances in the critically ill patient with oligoanuria. The patient's cardiac output provides the blood flow through the circuit; no pumps are necessary. A range of hemofilters is now available extending the applicability of CAVH to the pediatric population, including premature newborns. In this report the treatment of 15 neonates and 8 older children is described. Fluid overload was reduced in all cases. Reflecting the very grave clinical conditions of these patients, 15 of the 23 treated children ultimately died. Due to failure to control uremia, four patients required treatment with dialysis. CAVH was found to be generally safe and effective even in the hemodynamically unstable critically ill child.

Entities:  

Mesh:

Year:  1987        PMID: 3153297     DOI: 10.1007/bf00849232

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  12 in total

1.  Arteriovenous haemofiltration in hypervolaemia.

Authors:  G Zobel; M Trop; E Ring; C Suppan; H M Grubbauer
Journal:  Arch Dis Child       Date:  1986-08       Impact factor: 3.791

2.  Treatment of acute renal failure in an infant using continuous arteriovenous hemofiltration.

Authors:  K V Lieberman; L Nardi; J P Bosch
Journal:  J Pediatr       Date:  1985-04       Impact factor: 4.406

3.  Arterio-venous hemodiafiltration (A-V HDF): a possible way to increase urea removal during C.A.V.H.

Authors:  C Ronco
Journal:  Int J Artif Organs       Date:  1985-01       Impact factor: 1.595

4.  Early experience with continuous arteriovenous hemofiltration in critically ill pediatric patients.

Authors:  M R Leone; R D Jenkins; T A Golper; S R Alexander
Journal:  Crit Care Med       Date:  1986-12       Impact factor: 7.598

Review 5.  Continuous arteriovenous hemofiltration in acute renal failure.

Authors:  T A Golper
Journal:  Am J Kidney Dis       Date:  1985-12       Impact factor: 8.860

6.  Continuous arteriovenous hemofiltration. A report of six months' experience.

Authors:  A A Kaplan; R E Longnecker; V W Folkert
Journal:  Ann Intern Med       Date:  1984-03       Impact factor: 25.391

7.  Acute renal failure treated by slow continuous ultrafiltration. Preliminary report.

Authors:  A Synhaivsky; S B Kurtz; D N Wochos; B J Schniepp; W J Johnson
Journal:  Mayo Clin Proc       Date:  1983-11       Impact factor: 7.616

8.  Continuous arteriovenous hemofiltration in the critically ill patient. Clinical use and operational characteristics.

Authors:  A Lauer; A Saccaggi; C Ronco; M Belledonne; S Glabman; J P Bosch
Journal:  Ann Intern Med       Date:  1983-10       Impact factor: 25.391

9.  Acute renal failure in infants and children: outcome of 53 patients requiring hemodialysis treatment.

Authors:  E M Hodson; C M Kjellstrand; S M Mauer
Journal:  J Pediatr       Date:  1978-11       Impact factor: 4.406

10.  Treatment of acute renal failure in newborns by continuous arterio-venous hemofiltration.

Authors:  C Ronco; A Brendolan; L Bragantini; S Chiaramonte; M Feriani; A Fabris; R Dell'Aquila; G La Greca
Journal:  Kidney Int       Date:  1986-04       Impact factor: 10.612

View more
  14 in total

1.  Treatment of neonatal hyperbilirubinaemia by plasmapheresis.

Authors:  M South; W Butt
Journal:  Intensive Care Med       Date:  1992       Impact factor: 17.440

2.  Continuous arteriovenous haemofiltration in a neonate with hyperammonaemic coma due to citrullinaemia.

Authors:  W Sperl; R Geiger; H Maurer; C Murr; C Schmoigl; E Steichen-Gersdorf; M Sailer
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  Acute hypotension during continuous arteriovenous haemofiltration.

Authors:  S Picca; S Picardo; F Parisi; G Rizzoni
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

4.  Correction of hypernatraemia with continuous arteriovenous haemodiafiltration.

Authors:  G D Moss; R J Primavesi; M E McGraw; T L Chambers
Journal:  Arch Dis Child       Date:  1990-06       Impact factor: 3.791

Review 5.  Renal failure in the newly born.

Authors:  J T Brocklebank
Journal:  Arch Dis Child       Date:  1988-08       Impact factor: 3.791

6.  Continuous arteriovenous haemofiltration in the treatment of tumour lysis syndrome.

Authors:  D Heney; A Essex-Cater; J T Brocklebank; C C Bailey; I J Lewis
Journal:  Pediatr Nephrol       Date:  1990-05       Impact factor: 3.714

7.  Volumetric control of continuous haemodialysis in multiple organ failure.

Authors:  M G Bradbury; J T Brocklebank; E H Dyson; E Goutcher; A T Cohen
Journal:  Arch Dis Child       Date:  1995-01       Impact factor: 3.791

8.  Prevention of tumor lysis syndrome using continuous veno-venous hemofiltration.

Authors:  S L Saccente; E C Kohaut; R L Berkow
Journal:  Pediatr Nephrol       Date:  1995-10       Impact factor: 3.714

Review 9.  Management of acute renal failure.

Authors:  A Bagga
Journal:  Indian J Pediatr       Date:  1999 Mar-Apr       Impact factor: 1.967

10.  Operating characteristics of pediatric continuous arteriovenous hemofiltration in an animal model.

Authors:  H A Werner; M J Herbertson; M D Seear
Journal:  Pediatr Nephrol       Date:  1993-04       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.